Volume 10, Issue 2 (May 2025)                   JNFS 2025, 10(2): 272-281 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khalid M, Ghous H M A, Abid H M R. Efficacy of Bitter Melon Powder on Type 2 Diabetes. JNFS 2025; 10 (2) :272-281
URL: http://jnfs.ssu.ac.ir/article-1-1125-en.html
Department of Food Science and Technology, School of Food and Agricultural Sciences, University of Management and Technology Lahore, Pakistan
Abstract:   (254 Views)
Background: Momordica charantia (bitter melon) is commonly used in traditional medicine for the management of diabetes, due to its insulin-like properties. This study was conducted to assess the effectiveness of bitter melon powder in managing Type 2 diabetes by evaluating its impact on Random Blood Glucose (RBG), Fasting Blood Glucose (FBG), and Glycosylated Hemoglobin (HbA1c) levels. Methods: The study was carried out over five months at the Diabetic Clinic of Benazir Bhutto Hospital, Rawalpindi, involving 60 patients (30 males and 30 females) aged 35 to 60 years, selected through convenience sampling based on inclusion criteria. Patients were given 1/2 teaspoon of bitter melon powder daily before breakfast. The patients followed a sugar-free, low-fat diet, and blood glucose levels were measured through biochemical tests before and after the intervention. Data analysis and statistical validation were conducted using ANOVA. Results: The treatment group showed a significant reduction in RBG (244.43 to 201.20 mg/dl, P=0.001) compared to an increase in the control group (246.63 to 275.10 mg/dl, P=0.005). FBG decreased in the treatment group (11.21 to 10.43 mg/dl, P=0.02), while the control group slightly increased (11.21 to 11.26 mg/dl, P=0.10). HbA1c levels also dropped in the treatment group (8.09 to 7.62%, P=0.01) versus a rise in the control group (8.02 to 8.14%, P=0.09). Conclusions: The findings indicate that bitter melon supplementation can significantly lower blood glucose levels and provide a safe alternative to conventional diabetes treatments.
Full-Text [PDF 349 kb]   (68 Downloads) |   |   Full-Text (HTML)  (42 Views)  
Type of article: orginal article | Subject: public specific
Received: 2024/09/11 | Published: 2025/05/30 | ePublished: 2025/05/30

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 3.0 | Journal of Nutrition and Food Security

Designed & Developed by : Yektaweb